alcohol paxil, paxil withdrawl, paxil settlement, get off paxil, paxil withdrawls,
Paxil This page contains drug information on Paxil. The information provided includes the following: what is Paxil Paxil SSRI Side Effects Lawsuits: Suicide Claims If you or someone you know has been prescribed Paxil and have suffered serious side effects such as attempted suicide or birth defects, get the facts.Paxil
What is the most important information I should know about Paxil? Paxil Birth Defects, Paxil Side Effects and Infant Death On September 27, 2005, the FDA announced an alert to healthcare professionals and consumers as GlaxoSmithKline changed their warning label on Paxil (paroxetine) to include the risk of birth defects. The results of a recent study conducted by the two entities points to an increased risk of babies born with birth defects, specifically cardiovascular defects or congenital malformations, in instances where the mother was taking Paxil during the first trimester of pregnancy. Paxil, an antidepressant drug, is used by millions of people worldwide and generates more than $1 billion USD in annual sales. Paxil has been in the news previously for complaints of severe withdrawal symptoms and risks of suicidal behavior and increased violence in children and adolescents. Paxil is known as a Selective Serotonin Reuptake Inhibitor (SSRI); other SSRI drugs include Prozac, Zoloft, Celexa and Lexapro.
What is Paxil? The FDA warns physicians to carefully weigh the potential risks and benefits of prescribing or renewing Paxil prescriptions to women during pregnancy or while breast-feeding. It is important that all patients are aware of the side effects, risks, and treatment alternatives.
What should I discuss with my healthcare provider before taking Paxil? Panic Disorder: The effectiveness of PAXIL CR in the treatment of panic disorder was evaluated in three 10-week, multicenter, flexible-dose studies (Studies 1, 2, and 3) comparing paroxetine controlled-release (12.5 to 75 mg daily) to placebo in adult outpatients who had panic disorder (DSM-IV), with or without agoraphobia. These trials were assessed on the basis of their outcomes on 3 variables: (1) the proportions of patients free of full panic attacks at endpoint; (2) change from baseline to endpoint in the median number of full panic attacks; and (3) change from baseline to endpoint in the median Clinical Global Impression Severity score. For Studies 1 and 2, PAXIL CR was consistently superior to placebo on 2 of these 3 variables. Study 3 failed to consistently demonstrate a significant difference between PAXIL CR and placebo on any of these variables.
|
|
 |